Home › Skin Conditions › Alabama › Birmingham
Skin Conditions clinical trials in Birmingham, AL
5 studies for Skin Conditions are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
RecruitingPhase 3
- Cahaba Dermatology & Skin Health Center, Birmingham
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
RecruitingPhase 3
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology & Skin Health Center, Birmingham
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
RecruitingPhase 3
- Total Skin and Beauty Dermatology Center, PC, Birmingham
- University of Alabama at Birmingham, Birmingham
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
RecruitingPhase 2
- Site 117, Birmingham
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
About Skin Conditions
Your skin is your body's largest organ. It covers and protects your body. Learn about skin conditions, including causes, symptoms, and treatment.
More about Skin Conditions on MedlinePlus
Skin Conditions trials in other cities
- Indianapolis, IN6 studies
- Portland, OR5 studies
- Miami, FL5 studies
- Los Angeles, CA5 studies
- Phoenix, AZ5 studies
- Washington, DC4 studies
- Charlotte, NC4 studies
- Hollywood, FL4 studies
- Boston, MA4 studies
- New York City, NY4 studies
- Lewisville, TX4 studies
- Santa Clarita, CA4 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Ovarian Cancer25 studies
- Breast Cancer24 studies
- Non-Small Cell Lung Cancer23 studies
- Obesity22 studies
- Acute Myeloid Leukemia21 studies
- COPD17 studies
- Multiple Myeloma17 studies
- Cardiovascular Disease16 studies
- Endometrial Cancer16 studies
- Overweight16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.